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Daniel Brandeis, MD, PhD, Tobias Banaschewski, MD, PhD, Philip Asherson, MD, PhD,
Jonna Kuntsi, PhDObjective: Preterm birth has been associated with an
increased risk of attention-deﬁcit/hyperactivity disorder
(ADHD)–like symptoms and cognitive impairments
similar to those seen in ADHD, including attention and
inhibitory control difﬁculties. Yet data on direct compar-
isons across ADHD and preterm birth on cognitive-
neurophysiological measures are limited.
Method: We directly compared 186 preterm-born adoles-
cents to 69 term-born adolescents with ADHD and 135
term-born controls on cognitive-performance and event-
related potential measures associated with attentional
and inhibitory processing from a cued continuous perfor-
mance test (CPT-OX), which we have previously shown to
discriminate between the adolescents with ADHD and
controls. We aimed to elucidate whether the ADHD-like
symptoms and cognitive impairments in preterm-born
individuals reﬂect identical cognitive-neurophysiological
impairments in term-born individuals with ADHD.
Results: Go-P3 amplitude was reduced, reﬂecting im-
paired executive response control, in preterm-born ado-
lescents compared to both controls and adolescents with
ADHD. Moreover, in preterm-born adolescents, as inSupplemental material cited in this article is available online.
www.jaacap.orgterm-born adolescents with ADHD, contingent negative
variation amplitude was attenuated, reﬂecting impair-
ments in response preparation compared to controls.
Although the ADHD group showed signiﬁcantly increased
NoGo-P3 amplitude at FCz compared to preterm group, at
Cz preterm-born adolescents demonstrated signiﬁcantly
decreased NoGo-P3 amplitude compared to the control
group, similar to term-born adolescents with ADHD.
Conclusion: These ﬁndings indicate impairments in
response preparation, executive response control, and
response inhibition in preterm-born adolescents. Although
the response preparation and response inhibition impair-
ments found in preterm-born adolescents overlap with
those found in term-born adolescents with ADHD, the
preterm group also shows unique impairments, suggest-
ing more wide-ranging impairments in the preterm group
compared to the ADHD group.
Key words: ADHD, preterm birth, EEG, event-related
potential, neurocognitive impairment
J Am Acad Child Adolesc Psychiatry 2017;56(1):40–50.n the developed world, 8.6% of individuals are born
preterm (i.e., before 37 completed weeks of gestation).1I Although survival rates of preterm-born individuals
have increased greatly,2,3 preterm birth is associated with
the risk of adverse long-term outcomes.4,5 A meta-analysis
demonstrated that preterm-born children (n ¼ 1,556) were
at heightened risk (relative risk [RR] ¼ 2.64) for developing
attention-deﬁcit/hyperactivity disorder (ADHD) relative to
controls (n ¼ 1,720).4 A population-based study of Norwe-
gian adults further reported a 1.3- and 5-fold increased risk
for ADHD in adults born preterm (<37 weeks) and extremely
preterm (<28 weeks), respectively.6
ADHD is characterized by developmentally inappro-
priate and impairing levels of hyperactivity, impulsivity,and/or inattention.7 A meta-analysis in children with
ADHD showed impairments in sustained attention (indexed
by increased numbers of omitted responses or omission er-
rors), impairments in response inhibition (indexed by
increased numbers of error responses or commission errors),
and intraindividual ﬂuctuations in reaction times (reaction
time variability [RTV]) compared to controls.8 In adults with
ADHD, similar impairments have been reported.9-12 A
cognitive proﬁle that resembles that of individuals with
ADHD, including impairments in attention and inhibitory
control, is also frequently associated with preterm birth.13 A
meta-analysis of nine studies found that teacher- and parent-
rated attention problems in very preterm children (<33
weeks’ gestation) were 0.43 to 0.59 standard deviations
higher than for controls, respectively.13 Furthermore, im-
pairments in response inhibition have been found in chil-
dren14 and young adults15 born preterm.
Although research has provided strong support for the
link between preterm birth and ADHD, little is knownJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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EFFECT OF PRETERM BIRTH ON OFFSPRING ATTENTION AND INHIBITIONabout the underlying risk pathways. Cognitive performance
data alone provide only indirect insight into covert pro-
cessing as various covert mechanisms may result in indis-
tinguishable overt performance on cognitive tasks. The
study of event-related potentials (ERPs), which are electrical
potentials generated by the brain in response to internal or
external events such as stimuli and responses,16 allows direct
investigation of covert brain processes with millisecond
temporal resolution.17,18 ERP measures permit a sensitive
comparison of the cognitive-neurophysiological proﬁles
associated with preterm birth and ADHD, enabling us to
investigate whether the symptoms and impairments seen in
individuals born preterm are identical to those associated
with ADHD or whether they are part of more wide-ranging
impairments. Consequently, neurophysiological assessments
have the potential to further elucidate the risk pathways
underlying preterm birth and ADHD.
Although countless ERP studies have been conducted in
preterm-born infants in neonatal intensive care units19,20 and
in the postnatal period,21-23 less ERP research has been car-
ried out in children, adolescents, or adults born preterm. The
ERP studies that have been conducted in preterm-born
children have focused mainly on auditory ERP compo-
nents.24-26 Auditory ERP components are neurophysiolog-
ical correlates of cortical sound processing and sound
discrimination: they are generated involuntarily by the brain
during basic auditory encoding (indexed by the ERP
component P1) or as a response to a perceived change in
continuously repeated sounds (indexed by the ERP compo-
nents N2, mismatch negativity [MMN] and P3a).16 Re-
sponses to novel sounds (as indexed by N2, MMN, and P3a
amplitudes) are hypothesized to reﬂect an individual’s ca-
pacity to allocate attention.16,25 Auditory ERPs are therefore
useful to study attention in participants who cannot easily
respond behaviorally, such as young infants and children. In
auditory ERP studies, increased N2 amplitudes, interpreted
as reﬂecting impaired attention orienting, have been found
in children born very preterm (<32 weeks).24,26 Preterm-
born children have also demonstrated abnormalities in
other early sensory and attentional ERP components (MMN,
P1 and P3a).24-26 Despite this initial evidence for impair-
ments in ERP measures of attentional processing in preterm-
born individuals, the research overall is limited, and no
studies of preterm birth to date have investigated ERP
components that sensitively capture the attentional and
inhibitory impairments seen in individuals with ADHD.
One of the most common cognitive tasks used to study
attentional processing and response inhibition in individuals
with ADHD is the cued continuous performance test (CPT-
OX). The CPT-OX requires participants to detect target
stimuli among a sequence of distractor stimuli. Omission
errors (OE; the lack of a response to a target) are assumed to
represent impairments in sustained attention, whereas
commission errors (CE; responses to distractor stimuli) are
an index of response inhibition. ERPs associated with the
CPT are the Go-P3, which is an electrical potential generated
by the brain in response to the target stimulus, the NoGo-P3,
which is an electrical potential generated by the brain in
response to the distractor stimulus and reﬂects responseJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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variation (CNV), which occur in response to the cue stimulus
and are thought to reﬂect attentional orienting to a cue and
motor response preparation respectively. CPT performance
is typically impaired in individuals with ADHD, who usu-
ally demonstrate increased reaction time variability, a
greater number of OEs, and a greater number of CEs.8 In
addition, ERP studies using the CPT-OX have found that
individuals with ADHD also show impaired response inhi-
bition, response preparation, and attentional orienting as
indexed by reduced NoGo-P3, contingent negative variation
(CNV), and Cue-P3 amplitudes.27-29 Yet, not all studies have
reported casecontrol differences in Cue-P3 amplitude.30,31
Although some studies report attenuated Go-P3 amplitude
in individuals with ADHD,32-34 indexing impaired executive
response control, others show no case-control differ-
ences.27,28,35 Finally, case-control differences in N2 ampli-
tude in response to distractor stimuli (NoGo-N2) are
typically not found in the CPT-OX.28,31,36
Direct comparisons on ERP measures between preterm-
born individuals and term-born individuals with ADHD
are scarce. One ERP study investigated attentional process-
ing in very-low-birthweight children born preterm (<1,501 g
and <34 weeks) with and without ADHD, as well as in
term-born controls and term-born individuals with
ADHD.37 Term- and preterm-born children with ADHD,
who showed increased mean reaction time (MRT), RTV, and
a greater number of commission and omission errors on a
visual oddball paradigm, also demonstrated an increased
NoGo-N2 amplitude compared to term-born controls and
preterm-born participants without ADHD. However, the
sample size was small (n ¼ 41 across four groups). No study
to date has compared ERP components associated with
attentional and inhibitory processing in both ADHD and
preterm birth using a detailed measure of attention and
inhibitory control such as the CPT-OX.
We previously reported ﬁndings on ADHD casecontrol
differences on cognitive and neurophysiological markers of
ADHD. With the use of the CPT-OX, we demonstrated that
sustained attention (indexed by omission errors), response
inhibition (indexed by commission errors and NoGo-P3
amplitude), intraindividual ﬂuctuations in reaction times
(RTV), response preparation (indexed by CNV amplitude),
and attentional orienting (indexed by Cue-P3 amplitude)
successfully discriminated between adolescents with ADHD
and controls.38 Conﬂict monitoring as indexed by NoGo-N2
amplitude was not previously investigated in this sample of
ADHD and control adolescents.38 Having established the
cognitive-performance and ERP measures that sensitively
capture the attentional and inhibitory impairments in ado-
lescents with ADHD, we now compare new data obtained
from adolescents born preterm on identical measures to the
data previously obtained from the ADHD and control
participants.
In the current study, we therefore aim to establish
whether the cognitive impairments associated with preterm
birth, including attention and inhibitory control difﬁculties,
reﬂect neurophysiological impairments identical to those
observed in term-born individuals with ADHD.www.jaacap.org 41
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Sample
The sample consisted of 186 preterm-born participants (41 sibling
pairs, 104 singletons), 69 participants with ADHD (4 sibling pairs, 61
singletons) and 135 controls (61 sibling pairs, 13 singletons). The
groups differed signiﬁcantly in terms of age, IQ, sex distribution,
gestational age (GA), and ADHD symptom scores (Table 1). The
ADHD group showed signiﬁcantly higher ADHD symptoms and
functional impairment than both the preterm group (t¼16.55, df¼
178, p < .001, d ¼ 2.53; t ¼ 17.23, df ¼ 178, p < .001, d ¼ 2.94
respectively) and control group (t¼ 20.06, df¼ 134, p< .001, d¼ 3.74;
t¼ 19.70, df¼ 134, p< .001, d¼ 3.72 respectively). The preterm group
further demonstrated signiﬁcantly higher ADHD symptoms and
functional impairment than the control group (t ¼ 4.71, df ¼ 213, p <
.001, d ¼ 0.53; t ¼ 3.83, df ¼ 213, p < .001, d ¼ 0.45 respectively).
Although only 4% of the preterm participants were treated with
stimulant medication, 47% of the participants with ADHD were
treatedwith stimulantmedication at the time of the assessment. A 48-
hour ADHD medication-free period was required before assess-
ments. Written informed consent was obtained following procedures
approved by the London-Surrey Borders Research Ethics Committee
(09/H0806/58) and the National Research Ethics Service Committee
London—Bromley (13/LO/0068).
The preterm group was recruited from secondary schools in
Southeast England. All preterm participants had one full sibling
available for ascertainment and were born before 37 weeks’
gestation. Siblings of preterm-born individuals were included in
the preterm group if they were also born preterm (before 37
weeks’ gestation), to maximize the number of participants in the
preterm group. Term-born siblings of preterm-born individuals
were not included in this analysis. Most preterm-born participants
were of European white descent (84.6%). The other ethnicities
represented were British Asian (3.7%), mixed white and black
Caribbean (2.1%), mixed white and British Asian (1.6%), Indian
(1.1%), mixed white and Indian (1.1%), black Caribbean (0.5%),
mixed black and British Asian (0.5%), and other (2.7%). Seven in-
dividuals from the preterm sample were excluded because medical
birth records could not corroborate preterm status (GA 37
weeks). One individual was excluded because of an IQ of <70.
Eight preterm-born individuals met diagnostic criteria for a
research diagnosis of ADHD. Since here preterm birth is investi-
gated as a potential risk factor for ADHD, preterm-born in-
dividuals who demonstrated high levels of ADHD symptoms were
not excluded from the analysis (for the descriptive statistics and the
analysis of the sample without preterm-born individuals who metTABLE 1 Characteristics of Study Participants
ADHD n ¼ 69 Preterm n ¼ 186
GA, wk (SD) 39.9 (1.4) 33.0 (3.0)
GA range, wk 3,742 24e36
IQ (SD) 97.7 (13.8) 104.7 (12.3)
Age (SD), y 18.5 (3.0) 14.9 (1.9)
Age range, y 12.7e25.9 11.0e20.0
Males, % 88.4 54.3
Conners parent-rated ADHD
symptom score (SD)
35.8 (10.6) 11.2 (9.4)
BFIS score (SD) 16.4 (5.4) 3.7 (4.1)
Note: ADHD ¼ attention-deficit/hyperactivity disorder; BFIS ¼ Barkley Functional Imp
42 www.jaacap.orga research diagnosis for ADHD, see Supplement I and Table S1,
available online).
ADHD and control sibling pairs who had taken part in our
previous research39,40 were invited to take part in a follow-up
study.38 All participants were of European white descent and had
one full sibling available for ascertainment. Participants with ADHD
and their siblings were included in the ADHD group if they had a
clinical diagnosis of DSM-IV combined-type ADHD during child-
hood and met DSM-IV criteria for any ADHD subtype at follow-up.
Siblings of individuals with ADHD who did not meet DSM-IV
criteria for any ADHD subtype at follow-up were not included in
this analysis. The control group was initially recruited from primary
(aged 6–11 years) and secondary (aged 12–18 years) schools in the
United Kingdom, aiming for an age and sex match with the ADHD
sample. Control individuals and their siblings were included in the
control group if they did not meet DSM-IV criteria for any ADHD
subtype either in childhood or at follow-up.
Exclusion criteria for all groups were IQ of <70, general learning
difﬁculties, cerebral palsy or any other medical condition that affects
motor coordination including epilepsy, as well as brain disorders and
any genetic ormedical disorder thatmightmimicADHD. In addition,
preterm birth was an exclusion criterion in the ADHD and control
groups, because this study aimed to establish whether the cognitive
impairments associated with preterm birth reﬂect identical neuro-
physiological impairments in term-born individuals with ADHD.
We followed up the sample on average 5.8 years (SD ¼ 1.1) after
initial assessments. The ADHD and control groups were previously
included in a study investigating ADHD casecontrol differences on
cognitive and neurophysiological markers of ADHD persistence and
remission.38 Although ADHDcontrol differences for this sample
have been reported previously, here the ADHD and control groups
are compared to a group of preterm-born adolescents.
At follow-up, six participants from the ADHDsibling pair
sample were excluded from the group analyses because of missing
parent ratings of clinical impairment. Therefore, their current
ADHD status could not be determined. Two additional participants
from the ADHDsibling pair sample were excluded because of
drowsiness during the cognitive task. Two participants with
childhood ADHD, who did not meet ADHD symptom criteria but
did meet clinical levels of impairment at follow-up, were excluded
to minimize heterogeneity in the ADHD sample. In addition to
these exclusions, which are identical to those in our previous anal-
ysis,38 we also excluded six participants from the ADHDsibling
pair sample who were born preterm, as well as 12 individuals from
the ADHDsibling pair sample who provided no information
on GA.Control n ¼ 135
Statistic df p Value
— — —
39.9 (1.3) t ¼ e23.0 253 <.001
37e43 — — —
110.4 (12.2) t ¼ e3.2 253 .002
17.8 (2.1) t ¼ e12.0 253 <.001
11.9e21.6 — — —
75.6 t ¼ 4.6 253 <.001
7.0 (5.6) t ¼ 1.97 253 .050
2.1 (2.5) t ¼ e2.23 253 .027
airment Scale; GA ¼ gestational age.
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TABLE 2 Artifact-Free Segments per Trial in the Cued
Continuous Performance Test
Trial
ADHD
Mean (SD)
Preterm
Mean (SD)
Control
Mean (SD)
Cue 65.2 (6.6) 63.5 (7.0) 68.1 (6.0)
Go 34.3 (4.5) 33.9 (4.2) 36.4 (3.3)
NoGo 29.1 (3.4) 28.6 (3.1) 30.7 (3.1)
Note: Means and standard deviations (SD) for the attention-deficit/
hyperactivity disorder (ADHD), preterm, and control group are shown.
EFFECT OF PRETERM BIRTH ON OFFSPRING ATTENTION AND INHIBITIONSix control participants were removed from the analyses for
meeting DSM-IV ADHD criteria based on the parent-rated Barkley
Informant Rating Scale.41 In addition to these exclusions, which are
identical to those in our previous analysis,38 we also excluded 37
participants from the controlsibling pair sample because no GA
information was available.
Measures
Diagnostic Interview for ADHD in Adults. The Diagnostic Interview
for ADHD in Adults (DIVA)42 is a semi-structured interview
designed to evaluate the DSM-IV criteria for both adult and child-
hood ADHD symptoms and impairment. It consists of 18 items used
to deﬁne the DSM-IV symptom criteria for ADHD. Each item is
scored afﬁrmatively if the behavioral symptom was present often
within the past 6 months.
Conners’ Parent Rating Scale. Inattentive and hyperactive-
impulsive symptoms were measured using the Long Version of
Conners’ Parent Rating Scale.43 Summing the scores on the nine-
item hyperactive-impulsive and nine-item inattentive DSM-IV
symptoms subscales forms a total DSM-IV ADHD symptoms
subscale.
Barkley Functional Impairment Scale. The Barkley Functional
Impairment Scale (BFIS)41 is a 10-item scale used to assess the levels
of functional impairments commonly associated with ADHD
symptoms in ﬁve areas of everyday life: family/relationship; work/
education; social interaction; leisure activities; and management of
daily responsibilities. Each item ranged from 0 (never or rarely) to 3
(very often).
In the preterm and ADHD groups, ADHD was assessed using
parental ADHD symptom ratings on the DIVA and the BFIS for all
participants, for consistency. If participants were usually on stimu-
lant medication, parents were instructed to consider their children’s
ADHD symptoms off medication. A research diagnosis of ADHD
was made if participants scored six or more on either the inattention
or hyperactivity-impulsivity subscales of the DIVA and if they
received two or more positive scores on two or more areas of
impairment on the BFIS. In the control group, ADHD was assessed
using parental ADHD symptom ratings on the BFIS for all partici-
pants, for consistency. Control participants were excluded from the
analysis if they received two or more positive scores on two or more
areas of impairment on the BFIS.
IQ. The vocabulary and block design subtests of the Wechsler
Abbreviated Scale of Intelligence Fourth Edition (WASI-IV)44 were
administered to all participants to derive estimates of IQ.
Cued Continuous Performance Test. The CPT-OX is a cued Go/
NoGo task that probes attention, preparation, and response inhibi-
tion. The task consisted of 400 black letter arrays made up of a center
letter and incompatible ﬂankers on each side to increase difﬁculty.
The presented arrays included the cue letter O, the target letter X, as
well as the distractors H, B, C, D, E, F, G, J, and L. Cue and target
letters (O and X respectively) were ﬂanked by incompatible letters
(XOX and OXO respectively). Participants were instructed to ignore
the ﬂanking letters and respond as quickly as possible to cue-target
sequences (O-X). A total of 80 cues (XOX) were followed by the
target (OXO) in 40 trials (Go condition), and by neutral distractors in
the remainder of trials (NoGo condition). In 40 trials, the target letter
X was not preceded by a cue O and had to be ignored. Letters were
presented every 1.65 seconds for 150 milliseconds in a pseudo-
randomized order. Ten practice trials preceded the main task and
were repeated, if required, to ensure participant comprehension.
Participants were instructed to respond only to Cue-Go sequences
by pressing a button as quickly as possible with the index ﬁnger of
their preferred hand. Participants were further asked to withhold the
response in the presence of a NoGo stimulus, in the presence of a GoJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
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irrelevant letters. Task duration was 11 minutes.
Cognitive-performance measures obtained from the CPT-OX
include MRT (mean latency of response after target onset in milli-
seconds), RTV (standard deviation of target reaction time), and
number of errors. MRT and RTV were obtained from correct Go
trials. Errors included total omission errors (OE; nonresponses to Go
trials) and total commission errors (CE; responses to Cue, NoGo, or
distractor stimuli).
Procedure
Participants attended a single 4.5-hour research session, which
included an EEG assessment, an IQ test, and clinical interviews. As
part of the EEG assessment, participants completed a CPT with
ﬂankers (CPT-OX).45 The task was preceded by two 3-minute
resting-state recordings and was the ﬁrst of three cognitive EEG
tasks to be conducted during the testing session.
Electrophysiological Recording and Analysis
The EEG was recorded from a 62-channel direct-current coupled
(DCC) recording system (extended 10–20 montage), using a 500-Hz
sampling-rate, impedances less than 10 kU, and FCz as the
recording reference. The electro-oculograms were recorded from
electrodes above and below the left eye and at the outer canthi. The
EEG data were analyzed using Brain Vision Analyzer 2.0 (Brain
Products, Germany). Raw EEG recordings were down-sampled to
256 Hz, re-referenced to the average of all electrodes, and digitally
ﬁltered using Butterworth band-pass ﬁlters (0.130Hz, 24 dB/oct). All
trials were also visually inspected for electrical artifacts or obvious
movement, and sections of data containing artifacts were removed
manually. Ocular artefacts, corresponding to blink-related, vertical
and horizontal eye movements, were identiﬁed using the infomax
Independent Component Analysis (ICA) algorithm,46 which allows
for removal of the components associated with ocular artifacts by
back-projection of all but those components. Sections of data with
remaining artifacts exceeding 100 mV in any channel or with a
voltage step greater than 50 mV were automatically rejected.
For the CPT, stimulus-locked epochs (stimulus window
from 200 to 1,650 ms) were averaged based on three different
response conditions: Cue, Go, and NoGo. Averages were calculated
for trials with correct responses (Go) or correctly rejected trials
(NoGo and Cue), which included at least 20 artifact-free segments
(for the number of artifact-free segments per trial, see Table 2). Based
on previous research,27,28,47 ERP measures were identiﬁed within
selected electrodes and latency windows for which effects were
expected to be largest. These measures were then conﬁrmed sepa-
rately for the three groups using topographic maps.
In Cue trials, the P3 was measured at Pz between 300 and 650
milliseconds, and the CNV was measured at Cz and CPz between
1,300 and 1,650 milliseconds. In Go trials, the P3 was measured atwww.jaacap.org 43
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observed in Go trials, consistent with other studies using tasks with
low conﬂict-monitoring demands31,48 and was therefore not
included in the analysis. In NoGo trials, the P3 was measured at FCz
and Cz between 250 and 550 milliseconds and the N2 was measured
at Fz between 175 and 325 milliseconds.
Whereas ERP components with baseline correction are thought
to represent the absolute change in neural activity elicited by the
stimulus, ERP components without baseline correction are thought
to reﬂect the absolute state of neural activity measured at a given
time.49 Here, results are presented and interpreted without baseline
correction, as most previous ERP analyses on CPT-OX did not apply
a baseline correction,27,28,33,47,50 including the study partially over-
lapping with the current analysis.38 Moreover, there is evidence to
suggest that this approach may distort poststimulus topogra-
phies.49,50 However, to enable comparison with analyses in which
such corrections have been applied, analyses were rerun with
baseline correction (see Supplement II, available online).
Statistical Analysis
Fourteen preterm-born participants (7.5%) were excluded from the
ERP analysis of the Go condition, 16 preterm-born participants
(8.6%) were excluded from the ERP analysis of the NoGo condition,
and four preterm-born participants (2.2%) were excluded from the
ERP analysis of the Cue condition due to having fewer than 20
artifact-free segments available for analysis. Seven participants with
ADHD (10.1%) were excluded from the ERP analysis of the Go and
NoGo condition, and two participants with ADHD (2.9%) were
excluded from the ERP analysis of the Cue condition due to having
fewer than 20 artifact-free segments available for analysis. Two
control participants (1.5%) were excluded from the ERP analysis of
the Go condition, and six control participants (4.4%) were excluded
from the ERP analysis of the NoGo condition due to having fewer
than 20 artifact-free segments available for analysis.
Data were analyzed using random intercept models in Stata to
control for nonindependence of the data (i.e., data coming from
siblings of one family), using a “robust cluster” command to esti-
mate standard errors.51,52 Regression-based corrections for age wereTABLE 3 Cognitive and Event-Related Potential (ERP) Measures Fro
Site
ADHD (n ¼ 69) Preterm (n ¼
Mean SD Mean
MRT — 413.7 (20.7) 69.7 (66.4) 404.0 (-2.8) 7
RTV — 109.7 (23.0) 59.0 (57.2) 97.6 (-3.0) 5
OE — 2.5 (1.2) 3.8 (3.8) 1.7 (-0.1)
CE — 4.1 (0.9) 5.1 (5.4) 4.1 (-0.6)
Cue-P3 Pz 5.74 (-0.29) 3.9 (3.6) 7.44 (-0.27)
CNV Cz -2.30 (0.89) 4.7 (4.7) -2.75 (0.25)
CPz -2.31 (0.78) 4.5 (4.5) -2.16 (0.55)
Go-P3 CPz 8.30 (0.23) 6.3 (6.1) 8.28 (-0.76)
Pz 9.18 (0.58) 6.5 (6.2) 8.89 (-1.17)
NoGo-P3 FCz 6.14 (-1.21) 4.1 (4.2) 8.21 (0.48)
Cz 6.77 (-1.25) 4.3 (4.4) 6.56 (-0.70)
NoGo-N2 Fz -4.95 (-0.35) 3.2 (3.3) -6.02 (0.04)
Note: Means, standard deviations (SD), and effect sizes (Cohen’s d) for the attention-de
represent raw scores. Regression-based corrections are shown in bold in parentheses
Control; c ¼ Preterm vs. Control; CE ¼ commission errors; CNV ¼ contingent nega
RTV ¼ reaction time variability in milliseconds.
*p < .05.
44 www.jaacap.orgapplied to raw scores, and residual scores were analyzed. In addi-
tion, we reran all analyses on a carefully age-matched subsample
(aged 1419 years) due to signiﬁcant group mean differences in age
and the possibility of age effects on ERP measures (see Table S2 in
Supplement III for descriptive statistics, available online). All ana-
lyses controlled for sex. Results are presented both with and without
IQ as a covariate to empirically examine the effects of IQ on ERP
components. Correlations were also run to examine the associations
between ERP measures and DIVA ADHD symptom scores in the
preterm group. Effect sizes (Cohen’s d), which were calculated using
the difference in the means divided by the pooled standard devia-
tion,53 are reported. According to Cohen (1988), d ¼ 0.20 constitutes
a small effect, d ¼ 0.50 a medium effect, and d ¼ 0.80 a large effect.RESULTS
Cognitive-Performance Measures
No signiﬁcant main effects of group emerged for MRT
(z ¼ 1.21, p ¼ .225), RTV (z ¼ 0.55, p ¼ .585), the number of
total OE (z ¼ 0.38, p ¼ .707), and the number of total CE
(z ¼ 0.27, p ¼ .785) (Table 3). Because our previous analysis
of these ADHD and control groups showed casecontrol
differences with regard to RTV, we repeated the analysis
without the preterm group to see whether we could repeat
our previous ﬁndings. We suspected that the lack of
ADHDcontrol differences was due to a large preterm
group lying intermediate between the ADHD and control
groups. The random intercept model yielded signiﬁcant
main effects of group for RTV (z ¼ 2.13, p ¼ .021),
demonstrating signiﬁcantly lower RTV scores in the ADHD
group compared to the control group.
No signiﬁcant main effect of group emerged for MRT
(z ¼ 0.40, p ¼ .687), RTV (z ¼ 0.34, p ¼ .733), or the
numbers of total omission (OE; z ¼ 0.74, p ¼ .457) and
commission errors (CE; z ¼ 0.54, p ¼ .588) when IQ was
included as a covariate. DIVA ADHD symptom scores inm the Cued Continuous Performance Test
186) Control (n ¼ 135) Cohen’s d
SD Mean SD a b c
1.5 (69.7) 385.6 (-10.1) 48.0 (48.0) 0.34* 0.56* 0.12*
0.9 (49.0) 80.2 (-9.2) 58.3 (41.0) 0.51* 0.68* 0.13*
4.1 (4.1) 0.7 (-0.7) 1.4 (1.4) 0.32* 0.76* 0.19*
9.9 (9.9) 1.9 (-1.6) 2.2 (2.3) 0.17* 0.70* 0.13*
3.9 (3.8) 6.37 (0.22) 2.6 (2.4) 0.01* 0.18* 0.15*
2.2 (2.1) -3.65 (-0.50) 2.0 (2.0) 0.21* 0.44* 0.36*
2.4 (2.4) -3.78 (-0.79) 1.8 (1.8) 0.07* 0.52* 0.62*
5.2 (5.1) 8.81 (0.54) 4.1 (4.0) 0.18* 0.07* 0.28*
5.2 (5.0) 9.93 (1.05) 4.3 (4.1) 0.33* 0.10* 0.48*
5.0 (5.0) 8.00 (0.09) 4.7 (4.6) 0.36* 0.29* 0.14*
4.4 (4.4) 9.73 (1.86) 4.5 (4.6) 0.12* 0.65* 0.57*
4.0 (3.9) -4.69 (0.20) 3.2 (3.1) 0.10* 0.17* 0.04*
ficit/hyperactivity disorder (ADHD), preterm, and control group are shown. Values
. Moderate effect sizes are shown in italics. a ¼ ADHD vs. Preterm; b ¼ ADHD vs.
tive variation; MRT ¼ mean reaction time in milliseconds; OE ¼ omission errors;
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EFFECT OF PRETERM BIRTH ON OFFSPRING ATTENTION AND INHIBITIONthe preterm group were signiﬁcantly correlated with MRT
(r ¼ 0.20, p ¼ .030), RTV (r ¼ 0.22, p ¼ .015), OE (r ¼ 0.21,
p ¼ .019), and CE (r ¼ 0.22, p ¼ .015) when IQ was included
as a covariate.
ERP Results
Cue Condition. No signiﬁcant main effect of group emerged
for Cue-P3 amplitude (z ¼ 0.35, p ¼ .730). Because our
previous analysis of the ADHD and control groups showed
casecontrol differences on Cue-P3 amplitude, we repeated
the analysis without the preterm group to check whether we
could repeat our previous ﬁndings. We suspected that the
lack of ADHDcontrol differences was due to a large pre-
term group lying intermediate between the ADHD and
control groups. The random intercept model yielded a sig-
niﬁcant main effect of group for Cue-P3 amplitude
(z ¼ 2.26, p ¼ .024), demonstrating signiﬁcantly reduced
Cue-P3 amplitude in the ADHD group compared to the
control group. DIVA ADHD symptom scores in the preterm
group were not signiﬁcantly correlated with Cue-P3 ampli-
tude (r ¼ 0.018, p ¼ .843).
The random intercept model yielded a signiﬁcant main
effect of group for CNV amplitude (z ¼ 4.15, p < .001) and a
signiﬁcant group-by-recording site interaction (z ¼ 2.21,
p ¼ .027) (Figure 1). No signiﬁcant main effect of recording
site (Cz and CPz) (z ¼ 0.16, p ¼ .875) was found. Post hoc
tests revealed that the control group demonstrated signiﬁ-
cantly greater CNV amplitude at Cz compared to both the
ADHD (t ¼ 2.54, df ¼ 135, p ¼ .012) and preterm groups (t ¼
3.65, df ¼ 215, p < .001) with small-to-moderate effect sizesFIGURE 1 (A) Grand average event-related potentials (ERPs) to cu
the contingent negative variation (CNV) in the 1,300- to 1,650-millis
represented by dashed lines; preterm group represented by dotted li
maps for each group.
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VOLUME 56 NUMBER 1 JANUARY 2017(d ¼ 0.44 and d ¼ 0.38 respectively) (Table 3). The ADHD
and preterm groups did not differ signiﬁcantly with regard
to CNV amplitude at Cz (t ¼ 0.25, df ¼ 175, p ¼ .801).
Further post hoc tests revealed that the control group
demonstrated signiﬁcantly greater CNV amplitude at CPz
compared to both the ADHD (t ¼ 3.74, df ¼ 135, p < .001)
and preterm groups (t ¼ 6.42, df ¼ 215, p < .001), with
moderate effect sizes (d ¼ 0.60 and d ¼ 0.63 respectively)
(Table 3). The ADHD and preterm groups did not differ
signiﬁcantly with regard to CNV amplitude at CPz (t ¼ 1.02,
df ¼ 175, p ¼ .311). DIVA ADHD symptom scores in the
preterm group were not signiﬁcantly correlated with CNV
amplitude (r ¼ 0.018, p ¼ .843).
No signiﬁcant main effect of group emerged for Cue-P3
amplitude (z ¼ 1.04, p ¼ .299) when IQ was included as
a covariate. The random intercept model yielded a signiﬁ-
cant main effect of group for CNV amplitude (z ¼ 4.06,
p < .001) and a signiﬁcant group-by-recording site interac-
tion (z ¼ 2.21, p ¼ .027) when IQ was included as a covariate.
No signiﬁcant main effect of recording site (Cz and CPz) (z ¼
0.16, p ¼ .875) was found when IQ was included as a co-
variate. Post hoc tests revealed that the control group
demonstrated signiﬁcantly greater CNV amplitude at Cz
compared to the preterm group (t ¼ 2.88, df ¼ 215, p ¼ .004)
but not compared to the ADHD group (t ¼ 1.74, df ¼ 135,
p ¼ .083). The ADHD and preterm groups did not differ
signiﬁcantly with regard to CNV amplitude at Cz (t ¼ 0.19,
df ¼ 135, p ¼ .849). Further post hoc tests revealed that the
control group demonstrated signiﬁcantly greater CNV
amplitude at CPz compared to both the preterm (t ¼ 5.21,e stimuli at the Cz (above) and CPz (below) electrodes, showing
econd window (attention-deficit/hyperactivity disorder [ADHD]
nes; control group indicated by solid lines), and (B) topographic
www.jaacap.org 45
ROMMEL et al.df ¼ 215, p < .001) and ADHD (t ¼ 3.27, df ¼ 135, p < .001)
groups. The ADHD and preterm groups did not differ
signiﬁcantly with regard to CNV amplitude at CPz (t ¼ 1.37,
df ¼ 175, p ¼ .174).
Go Condition. The random intercept model yielded a
signiﬁcant main effect of group for Go-P3 amplitude
(z ¼ 2.86, p ¼ .004) (Figure 2). No signiﬁcant main effect of
recording site (CPz and Pz) (z ¼ 0.14, p ¼ .892) and no
group-by-recording site interaction (z ¼ 1.90, p ¼ .057)
were found. Post hoc tests revealed that Go-P3 amplitude in
the ADHD group was not signiﬁcantly different from Go-P3
amplitude in the control (t ¼ 1.67, df ¼ 131, p ¼ .097) and
preterm groups (t ¼ 1.35, df ¼ 169, p ¼ .178). The preterm
group demonstrated signiﬁcantly attenuated Go-P3 ampli-
tude compared to the control group (t ¼ 3.08, df ¼ 208, p ¼
.002), with a small effect size (d ¼ 0.36) (Table 3). DIVA
ADHD symptom scores in the preterm group were not
signiﬁcantly correlated with Go-P3 amplitude (r ¼ 0.019,
p ¼ .841).
The random intercept model yielded a signiﬁcant main
effect of group for Go-P3 amplitude (z ¼ 2.80, p ¼ .005)
when IQ was included as a covariate. No signiﬁcant main
effect of recording site (CPz and Pz) (z¼ 0.14, p¼ .892) and no
group-by-site interaction (z ¼ 1.90, p ¼ .058) was found
when IQ was included as a covariate. Post hoc tests revealed
that Go-P3 amplitude in the ADHD group was not signiﬁ-
cantly different from Go-P3 amplitude in the control
(t¼1.63, df¼ 131, p¼ .105) and preterm groups (t¼1.71,
df ¼ 169, p ¼ .090) when IQ was included as a covariate. The
preterm group demonstrated signiﬁcantly attenuated Go-P3
amplitude compared to the control group (t ¼ 2.89,
df ¼ 208, p ¼ .004) when IQ was included as a covariate.FIGURE 2 (A) Grand average event-related potentials (ERPs) to G
the Go-P3 in the 250- to 500-millisecond window (attention-deficit/
preterm group represented by dotted lines; control group indicated
46 www.jaacap.orgNoGo Condition. The random intercept model yielded no
signiﬁcant main effect of group for NoGo-N2 amplitude (z ¼
0.08, p ¼ .940). NoGo-N2 amplitude was not previously
investigated in this sample of adolescents with ADHD and
controls.38 For NoGo-P3 amplitude, no signiﬁcant main ef-
fect of group (z ¼ 1.01, p ¼ .313) and recording site (FCz
and Cz) (z ¼ 0.03, p ¼ .978) emerged (Figure 3). However, a
signiﬁcant group-by-recording site interaction emerged for
NoGo-P3 amplitude (z ¼ 4.77, p < .001). Post hoc tests
revealed that the ADHD group showed signiﬁcantly atten-
uated NoGo-P3 amplitude at FCz compared to the preterm
group (t ¼ 2.56, df ¼ 170, p ¼ .011), with small effect size
(d ¼ 0.37), but not compared to the control group (t ¼ 1.72,
df ¼ 131, p ¼ .088). No signiﬁcant difference in NoGo-P3
amplitude at FCz emerged between preterm and control
participants (t ¼ 0.41, df ¼ 207, p ¼ .685). Although the
ADHD and preterm groups demonstrated no signiﬁcant
difference in NoGo-P3 amplitude at Cz (t ¼ 0.53, df ¼ 170,
p ¼ .599), both the ADHD (t ¼ 3.84, df ¼ 131, p < .001) and
preterm (t ¼ 4.00, df ¼ 207, p < .001) groups showed
signiﬁcantly attenuated NoGo-P3 amplitude at Cz compared
to the control group, with moderate effect sizes (d ¼ 0.63 and
d ¼ 0.54). DIVA ADHD symptom scores in the preterm
group were signiﬁcantly negatively correlated with NoGo-
P3 amplitude (r ¼ 0.20, p ¼ .029).
The random intercept model yielded no signiﬁcant main
effect of group for NoGo-N2 amplitude (z ¼ 0.20,
p ¼ .838) when IQ was included as a covariate. For NoGo-P3
amplitude, no signiﬁcant main effect of group (z ¼ 0.84,
p ¼ .403) and recording site (FCz and Cz) (z ¼ 0.03,
p ¼ .978) emerged when IQ was included as a covariate.
However, a signiﬁcant group-by-recording site interactiono stimuli at the CPz (above) and Pz (below) electrodes, showing
hyperactivity disorder [ADHD] represented by dashed lines;
by solid lines), and (B) topographic maps for each group.
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FIGURE 3 (A) Grand average event-related potentials (ERPs) to NoGo stimuli at the FCz (above) and Cz (below) electrodes,
showing the NoGo-P3 in the 250- to 500-millisecond window (attention-deficit/hyperactivity disorder [ADHD] represented by
dashed lines; preterm group represented by dotted lines; and the control group indicated by solid lines), and (B) topographic maps
for each group.
EFFECT OF PRETERM BIRTH ON OFFSPRING ATTENTION AND INHIBITIONemerged for NoGo-P3 amplitude (z ¼ 4.79, p < .001)
when IQ was included as a covariate. Post hoc tests revealed
that the ADHD group showed signiﬁcantly attenuated
NoGo-P3 amplitude at FCz compared to the preterm group
(t ¼ 2.01, df ¼ 170, p ¼ .046), but not compared to the control
group (t ¼ 1.38, df ¼ 131, p ¼ .170). No signiﬁcant differ-
ence in NoGo-P3 amplitude at FCz emerged between pre-
term and control participants (t ¼ 0.67, df ¼ 207, p ¼ .504).
Although the ADHD and preterm groups demonstrated no
signiﬁcant difference in NoGo-P3 amplitude at Cz (t ¼ 0.08,
df ¼ 170, p ¼ .938), both the ADHD (t ¼ 3.29, df ¼ 131, p <
.001) and preterm groups (t ¼ 3.53, df ¼ 207, p < .001)
showed signiﬁcantly attenuated NoGo-P3 amplitude at Cz
compared to the control group when IQ was included as a
covariate.
Excluding the eight preterm-born individuals meeting
diagnostic criteria for a research diagnosis of ADHD from
the analyses did not alter the results (Figures S1S3, avail-
able online).
With the exception of the CNV ﬁndings, cognitive-
performance and ERP results remain unchanged in the
age-matched analysis (Table S3, available online). The pre-
term group of the age-matched subsample demonstrated
signiﬁcantly attenuated CNV amplitude compared to the
control group but not compared to the ADHD group. The
ADHD and control groups of the age-matched sample did
not differ signiﬁcantly with regard to CNV amplitude.DISCUSSION
Here, we directly compared preterm-born adolescents to
term-born adolescents with ADHD and term-born controls
on cognitive performance and ERP measures from the CPT-
OX, which sensitively capture the attentional and inhibitoryJOURNAL OF THE AMERICAN ACADEMY OF CHILD & ADOLESCENT PSYCHIATRY
VOLUME 56 NUMBER 1 JANUARY 2017impairments in adolescents with ADHD. We provide evi-
dence for executive response control (Go-P3), response
preparation (CNV), and response inhibition (NoGo-P3)
impairments in preterm-born individuals. Although the
observed impairment in executive response control (Go-P3)
represents preterm birth-speciﬁc impairments, response
preparation (CNV) and response inhibition (NoGo-P3)
impairments were also observed in individuals with
ADHD.38 The current study constitutes the ﬁrst cognitive-
neurophysiological comparison of attentional and inhibi-
tory processing in adolescents born preterm and term-born
adolescents with ADHD using a detailed measure of
attention and inhibitory control, and furthers our under-
standing of impairments of response preparation, executive
response control, and response inhibition in preterm-born
adolescents.
Our ERP results show a signiﬁcant group difference in P3
amplitude in response to Go stimuli, which was reduced in
preterm-born adolescents compared to the control group.
The Go-P3 has been linked to several attentional functions,
such as evaluation of stimuli and resource allocation,54,55
and may reﬂect aspects of executive response control.27,28
Although an association between preterm birth and lower
mean IQ scores has consistently been reported,56 our ﬁnding
of a preterm birthspeciﬁc impairment is unlikely due to
lower general cognitive ability, because our preterm group
did not differ signiﬁcantly from the control group on
IQ scores, and including IQ as a covariate had no effect on
the results. However, as this is the ﬁrst investigation of
its kind, the ﬁnding of reduced Go-P3 amplitude in preterm-
born adolescents compared to controls requires replication.
In line with the majority of previous research, we found
no Go-P3 differences between the ADHD and control
groups.27,28,35,57www.jaacap.org 47
ROMMEL et al.Response inhibition impairments, as indexed by abnormal
NoGo-P3 amplitude, were observed in the preterm-born
adolescents. These impairments were linked to the
increased ADHD symptoms in the preterm group. Our pre-
vious research had also established response inhibition im-
pairments, reﬂected by decreased NoGo-P3 amplitude, in
adolescents with ADHD.38 The signiﬁcant group-by-
recording site interactions in the current study, supported by
topographic maps of NoGo-P3 mean amplitude, indicate,
however, a degree of group speciﬁcity in relation to response
inhibition impairments. Although both the ADHD38 and
preterm groups demonstrated signiﬁcantly reduced NoGo-
P3 amplitude compared to controls at the vertex, the pre-
term group showed a more frontal scalp distribution of the
NoGo-P3 component compared to adolescents with ADHD
and controls, which was signiﬁcantly greater than NoGo-P3
amplitude in the ADHD group, suggesting greater neuro-
physiological immaturity.29,58,59 These neurophysiological
ﬁndings extend previous cognitive research, which has
indicated impairments in response inhibition in individuals
born preterm,60-62 and suggest an overlapping neurophysi-
ological impairment as well as a degree of group speciﬁcity.
We further identiﬁed the same CNV abnormalities in the
preterm group as observed in individuals with ADHD,38
suggestive of impaired attentional orienting and response
preparation.57 The attenuated CNV amplitude in adoles-
cents born preterm is in accordance with previous evidence
of abnormalities in attentional orienting as indexed by larger
N2 and reduced P3a components in children born pre-
term.24-26 The lack of a difference among the three groups
with regard to conﬂict monitoring as indexed by NoGo-N2
amplitude is inconsistent with previous research demon-
strating abnormalities in NoGo-N2 amplitude in children
born very preterm (<32 weeks) using an auditory oddball
paradigm,24,26 as well as in individuals with ADHD using
ﬂanker tasks.63-65 However, the CPT-OX is a task with
relatively low conﬂict-monitoring demands, and previous
studies using the CPT-OX have also not been able to
demonstrate an attenuated NoGo-N2 in individuals with
ADHD.27,28,47 Similarly, we found no difference in Cue-P3
amplitude between the preterm-born adolescents and the
ADHD and control groups. These ﬁndings do not replicate
auditory ERP studies, which demonstrated abnormalities in
early attentional ERP components (P1 and P3a) in preterm-
born children.24-26 However, overall research is limited,
and no study to date has investigated attention orienting as
indexed by Cue-P3 amplitude in adolescents born preterm.
Further studies should explore the differences between in-
dividuals born preterm and individuals with ADHD in tasks
with higher conﬂict-monitoring demands to examine conﬂict
monitoring as indexed by NoGo-N2 amplitude. In addition,
future research needs to establish whether individuals born
preterm demonstrate impairments in attentional orienting as
indexed by Cue-P3 amplitude.
No signiﬁcant differences in mean reaction time (MRT),
reaction time variability (RTV), omission errors (OE), and
commission errors (CE) were found between the preterm
and control groups, suggesting that preterm-born adoles-
cents may be able to compensate for the impairment seen in48 www.jaacap.orgthe brain processes involved in response preparation, exec-
utive response control, and response inhibition. As reported
previously, the ADHD group demonstrated signiﬁcantly
increased MRT and RTV and a greater number of OEs
compared to both preterm and control groups,38 in line with
previous research.8,10-12,66
A limitation of this study is that we were unable to inves-
tigate whether risk factors for being preterm (e.g., poverty,
malnutrition) might account for the ERP ﬁndings in our
sample. Although population-based quasi-experimental de-
signs have established that the associations between preterm
birth and psychiatric morbidity are largely independent of
shared familial confounds and measured covariates, consis-
tent with a causal inference,5 future research should take risk
factors for preterm birth into account when examining
cognitive-neurophysiological measures in preterm-born in-
dividuals. Finally, theDIVA is a diagnostic interview for adult
ADHD, butwas used across ages in this study for consistency.
The DIVA followsDSM criteria for ADHD closely. It inquires
about the presence of ADHD symptoms in adulthood as well
as in childhood, and about the chronicity of these symptoms,
and it can therefore be easily adapted for use in younger
participants. Nonetheless, future studies should apply diag-
nostic measures normed for their population.
In conclusion, this study provides evidence for impair-
ments in brain processes involved in response preparation,
executive response control, and response inhibition in ado-
lescents born preterm. Although some of the impairments
found in adolescents born preterm overlap with those found
in term-born adolescents with ADHD, the preterm group
also shows unique impairments, indicating more wide-
ranging impairments in the preterm group, compared to
individuals with ADHD. This idea is supported by research
suggesting that, as well as being a risk factor for ADHD,
preterm birth presents a risk factor for other psychiatric
disorders, such as schizophrenia, bipolar disorder, and
autism spectrum disorder.5,67-69 The late third trimester (32–
40 weeks’ gestation) serves as a critical period to lay the
foundation of vital brain networks.70,71 It is therefore
conceivable that preterm birth may result in trauma to the
brain networks associated with ADHD, as well as networks
associated with additional impairments. These results, and
the ﬁndings that ADHD symptom scores were increased in
the preterm group compared to controls, suggest that pre-
term birth may present a risk factor for both ADHD and
additional impairments. Routine psychiatric screening to
facilitate early psychological referral is therefore likely to be
beneﬁcial in this vulnerable population. As this is one of the
ﬁrst studies to directly compare preterm-born adolescents to
term-born adolescents with ADHD and term-born controls
on cognitive performance and ERP measures of attention
and inhibitory control, these ﬁndings require replication in
larger-scale studies with similar-size groups and additional
research looking at broader forms of psychopathology. &JOAccepted October 18, 2016.
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